UNSPSC 51331902: Lithium citrate

This classification denotes an antipsychotic agent with the molecular formula C6H5O7.3Li.4H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5Z6E9K79YV, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, trilithium salt but generally known as lithium citrate, which bears US NIH Compound Identifier 13520. European Medicines Agency schedules Lithium citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14377MIG. Most nations schedule lithium citrate under HS 29181590 and SITC 51391.

As of Q4 2014, LITHIUM CITRATE remains the US FDA Preferred Term for this commodity. Lithium citrate bears US NLM identifiers UMLS ID C0125997 and NCI Concept Code C61812. SMILES: OC(CC(=O)O)(CC(=O)O)C(=O)O.[LI].[LI].[LI].

UNSPSC 51331902 Lithium citrate is a Commodity code that in recent state and local procurement activity covers pharmaceutical and medical supply procurement, though the single tracked opportunity shows a mismatch between the code's nominal scope and the work actually being solicited. Seminole County, Florida posted an IFB for naloxone and drug deactivation systems—opioid-reversal medications and harm-reduction equipment—rather than lithium citrate itself. State and local health departments, county public health authorities, and community health agencies appear to be the primary issuing bodies under this code family, often procuring through competitive sealed-bid processes to support public health and emergency-response initiatives. Vendors typically must meet standard compliance requirements including drug-free workplace certification, E-Verify eligibility verification, and appropriate insurance coverage (workers' compensation, commercial general liability, and professional liability).

Seminole County, Florida is the primary geographic activity center visible in recent records. Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the procurement included a two-year initial term with one-year renewal option and indicated potential FEMA funding with associated federal compliance requirements. The code shows limited recent relevant activity—the single tracked opportunity does not align with lithium citrate's pharmaceutical scope—suggesting either minimal current state and local demand for this specific commodity or potential code-tagging inconsistencies in procurement systems.